ImmuCell Corporation Common Stock (ICCC)
Since Feb 22, 2022, ImmuCell Corporation Common Stock (ICCC) has reported earnings 20 times. On average the shares move ±3.23% post-earnings, with a positive reaction 80.0% of the time. Its largest post-earnings gain was +8.92% (Feb 21, 2023) and its largest decline was -9.16% (May 14, 2024). The next earnings report is predicted for 2026-11-13 (estimated).
Earnings reactions
How ICCC moved on each past earnings report.
Earnings Impact
Total Earnings
20
Avg Abs. Movement
±3.23%
Positive %
80.0%
Negative %
20.0%
Historical Earnings Statistics
| Date | Timing | Earnings move | SEC Filing |
|---|---|---|---|
| Jul 09, 2026 | ☽ POST | +0.53% | open_in_new |
| May 14, 2026 | ☽ POST | +4.74% | open_in_new |
| Apr 08, 2026 | ☽ POST | +0% | open_in_new |
| Mar 04, 2026 | ☽ POST | +2.26% | open_in_new |
Earnings Count
20
Total earnings in dataset
Avg Abs. Movement
±3.23%
Avg % price change on earnings
Institutional ownership
Holdings as of Mar 31, 2026 · SEC 13-F
SEC Filing Types
Recent SEC Filings
7 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 8-K | 20260709 | open_in_new SEC.gov |
| 4 | 20260622 | open_in_new SEC.gov |
| 8-K | 20260617 | open_in_new SEC.gov |
| 8-K | 20260610 | open_in_new SEC.gov |
| 10-Q | 20260514 | open_in_new SEC.gov |
| 8-K | 20260514 | open_in_new SEC.gov |
| 10-K/A | 20260513 | open_in_new SEC.gov |
Frequently asked about ICCC earnings
When does ImmuCell Corporation Common Stock report earnings next? expand_more
ImmuCell Corporation Common Stock (ICCC)'s next earnings date is estimated for 2026-11-13. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does ICCC stock move after earnings? expand_more
Over 20 reports, ICCC has moved an average of ±3.23% the session after earnings, closing higher 80.0% of the time.
What was ICCC's biggest post-earnings move? expand_more
ICCC's largest post-earnings gain on record was +8.92% on Feb 21, 2023, and its largest decline was -9.16% on May 14, 2024.
Where can I find ImmuCell Corporation Common Stock's SEC filings? expand_more
All of ImmuCell Corporation Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right